Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms
Clinical trial NCT05000346 · TERMINATED
Trial details
- NCT number
- NCT05000346
- Sponsor
- Aquilon Pharmaceuticals S.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2022-12-21
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.